Skip to content

Effects of Bupivacaine Liposome for Bilateral Erector Spinae Plane Block on Postoperative Analgesia in Posterior Lumbar Spine Surgery

Effects of Bupivacaine Liposome for Bilateral Erector Spinae Plane Block on Postoperative Analgesia in Posterior Lumbar Spine Surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600117824
Enrollment
Unknown
Registered
2026-01-29
Start date
2026-02-01
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative pain after lumbar spine surgery

Interventions

Bupivacaine Liposome Local Infiltration Group:Periwound local infiltration anesthesia with bupivacaine liposome
Bupivacaine Liposome ESPB Group:Ultrasound-guided bilateral erector spinae plane block was administered to the ESPB group prior to general anesthesia induction

Sponsors

Shaanxi 215 Hospital of nuclear industry
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Patients between 18 and 80 years of age; 2.Patients scheduled for posterior lumbar spine surgery (1-3 levels); 3.ASA grades 1-3; 4.BMI of 18.0 to 29.9 kg/m^²; 5.Informed consent was obtained from all patients or their legal representatives;

Exclusion criteria

Exclusion criteria: 1.Allergy to bupivacaine or any component of the liposomal formulation; 2.Pre-existing spinal cord injury; 3.Congenital spinal deformity; 4.Concomitant malignant tumor; 5.Severe systemic diseases, such as cardiopulmonary insufficiency, hepatic or renal dysfunction; 6.Chronic preoperative use of opioids or other analgesics leading to drug tolerance; 7.Coagulopathy or local infection at the potential puncture site(s); 8.Psychiatric disorders or cognitive impairment that would preclude cooperation with the study procedures; 9.Refusal to use a postoperative intravenous patient-controlled analgesia (PCA) pump; 10.Pregnancy or lactation;

Design outcomes

Primary

MeasureTime frame
Postoperative 72-hour opioid consumption;

Secondary

MeasureTime frame
Satisfaction with postoperative analgesia;Time to first ambulation and ambulation distance;The incidence of complications within 72 hours postoperatively, such as respiratory depression, nausea and vomiting, dizziness, and somnolence.;Consumption of rescue analgesics and time to first rescue analgesia;Intraoperative consumption of anesthetic agents;Pittsburgh Sleep Quality Index (PSQI) score;Static and dynamic NRS scores and NRS-AUC within the first 72 postoperative hours;Chronic pain;Length of hospital stay;Time to return of bowel function;

Countries

China

Contacts

Public ContactLiuqin Jiang

Shaanxi 215 Hospital of nuclear industry

jlq215hp@163.com+86 29 3208 8348

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 7, 2026